These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18653907)

  • 1. Comorbidities among HIV-infected injection drug users in Chennai, India.
    Solomon SS; Hawcroft CS; Narasimhan P; Subbaraman R; Srikrishnan AK; Cecelia AJ; Suresh Kumar M; Solomon S; Gallant JE; Celentano DD
    Indian J Med Res; 2008 May; 127(5):447-52. PubMed ID: 18653907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India.
    Solomon SS; Srikrishnan AK; Celentano DD; Johnson SC; Vasudevan CK; Murugavel KG; Anand S; Kumar MS; Solomon S; Mehta SH
    BMC Public Health; 2011 Jan; 11():39. PubMed ID: 21235816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
    Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.
    Solomon SS; Srikrishnan AK; Mehta SH; Vasudevan CK; Murugavel KG; Thamburaj E; Anand S; Kumar MS; Latkin C; Solomon S; Celentano DD
    J Acquir Immune Defic Syndr; 2008 Nov; 49(3):327-32. PubMed ID: 18845962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India.
    Mehta SH; Vogt SL; Srikrishnan AK; Vasudevan CK; Murugavel KG; Saravanan S; Anand S; Kumar MS; Ray SC; Celentano DD; Solomon S; Solomon SS
    Indian J Med Res; 2010 Dec; 132(6):706-14. PubMed ID: 21245619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border region.
    Zhou YH; Liu FL; Yao ZH; Duo L; Li H; Sun Y; Zheng YT
    PLoS One; 2011 Jan; 6(1):e16349. PubMed ID: 21283696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk behaviors, prevalence of HIV and hepatitis C virus infection and population size of current injection drug users in a China-Myanmar border city: results from a Respondent-Driven Sampling Survey in 2012.
    Li L; Assanangkornchai S; Duo L; McNeil E; Li J
    PLoS One; 2014; 9(9):e106899. PubMed ID: 25203256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection.
    Hsieh MH; Tsai JJ; Hsieh MY; Huang CF; Yeh ML; Yang JF; Chang K; Lin WR; Lin CY; Chen TC; Huang JF; Dai CY; Yu ML; Chuang WL
    PLoS One; 2014; 9(4):e94791. PubMed ID: 24722534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
    Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
    Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
    Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
    J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality among injection drug users in Chennai, India (2005-2008).
    Solomon SS; Celentano DD; Srikrishnan AK; Vasudevan CK; Anand S; Kumar MS; Solomon S; Lucas GM; Mehta SH
    AIDS; 2009 May; 23(8):997-1004. PubMed ID: 19367155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya.
    Webale MK; Budambula V; Lihana R; Musumba FO; Nyamache AK; Budambula NL; Ahmed AA; Ouma C; Were T
    BMC Infect Dis; 2015 Jul; 15():299. PubMed ID: 26223795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
    Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ
    World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India.
    Solomon SS; Celentano DD; Srikrishnan AK; Vasudevan CK; Murugavel KG; Iqbal SH; Anand S; Kumar MS; Latkin C; Solomon S; Mehta SH
    Am J Epidemiol; 2010 Dec; 172(11):1259-67. PubMed ID: 20935070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
    Tun W; Vu L; Adebajo SB; Abiodun L; Sheehy M; Karlyn A; Njab J; Ahonsi B; Issa BK; Idogho O
    Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004.
    Larsen C; Pialoux G; Salmon D; Antona D; Le Strat Y; Piroth L; Pol S; Rosenthal E; Neau D; Semaille C; Delarocque Astagneau E
    Euro Surveill; 2008 May; 13(22):. PubMed ID: 18761958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.